Shulman John D's Form 4 filing
Petros Pharmaceuticals, Inc. (PTPI) · filed Jan 3, 2022
- Accession no.
- 0001104659-22-000036
- Filed
- Jan 3, 2022, 6:13 AM ET
- Trade date
- Dec 22, 2021
- Filing delay
- 12 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $500.0K. It was filed 12 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shulman John DCIK 0001208886 | Director, 10% Owner |
| JCP III SM Aiv, L.P.CIK 0001835386 | 10% Owner |
| Juggernaut Partners III GP, L.P.CIK 0001835421 | 10% Owner |
| Juggernaut Partners III GP, Ltd.CIK 0001835433 | 10% Owner |
| METP Holdings LLCCIK 0001836319 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +145,773 | $3.43 | +$500,001.39 | 5,703,544 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | PPurchaseAcquired | +109,329 | $0.00 | $0 | 109,329 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.